GNRC vs SYRE · P/E 82, rev $1.17B vs $7.60B cap
Generac Holdings Inc (GNRC) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported GNRC revenue for 2026-06-30 was $1.17B. Net income was $143.2M. Revenue was up 10.8% from 2026-03-31 to 2026-06-30. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
GNRC currently screens at market cap $15.40B and trailing P/E 82.0. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the GNRC and SYRE stock pages for the full models.
Not investment advice.